the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

The Vaccines 2008: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

Published by Kalorama Information Contact us : +1-860-674-8796
Published 2008/04 Content info 230 pages
Product code KL64389
Price From  US $ 4100 Order/Price list
US $ 4100 PDF by E-mail (Single User License)
US $ 4500 Hard Copy
US $ 4900 PDF by E-mail (Single User License) & Hard Copy
US $ 5995 PDF by E-mail (10 User License)
US $ 8200 PDF by E-mail (Global Site License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • The Global Vaccine Industry
    • Scope And Methodology
    • Overview
    • Pediatric Preventative Vaccines
  • The Market
    • Adult Preventative Vaccines
  • The Market
  • Total Vaccine Market
  • Issues and Trends
  • A "Gardasil Effect" in R&D?

CHAPTER TWO: INTRODUCTION TO VACCINES

  • A Brief History: The Development of Vaccines
  • The Immune Response
  • Mechanism of Action
  • Types of Vaccines
    • Attenuated (Weakened) Live Viruses
    • Killed (Inactivated) Viruses
    • Toxoid Vaccines
    • Genetically Engineered/Modified Vaccines
      • Subunit Vaccines
      • Conjugate Vaccines
      • DNA Vaccination
  • Vaccine Approval Process

CHAPTER THREE: PEDIATRIC VACCINES

  • Introduction
  • Childhood Immunization in the United States
    • Childhood Immunization Rates
    • Challenges to the Vaccine Delivery System
    • Recommended Childhood Immunization Schedule
    • State Immunization Recommendations
  • Pediatric Vaccine Products
    • BCG Vaccines
    • Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio Vaccines
      • Diphtheria
      • Pertussis
      • Tetanus
      • Hepatitis B
      • Poliomyelitis
    • Haemophilus Influenzae Type B Vaccines
    • Hepatitis A Vaccines
    • Measles, Mumps and Rubella Vaccines
      • Measles
      • Mumps
      • Rubella
    • Pneumococcal Conjugate Vaccine
    • Rotavirus Vaccines
    • Varicella Vaccines
    • Meningococcal Vaccines
  • Cost of Vaccines in the United States
  • Pediatric Vaccines in Development
    • Global Initiatives for Vaccine Research
      • Enterotoxigenic Escherichia coli
      • Parainfluenza Virus Type 3
      • Pneumococcal Vaccines
      • Respiratory Syncytial Virus
  • The World Market for Pediatric Preventive Vaccines
    • Total Market Size and Forecast
    • DTP and DTaP Vaccine Market
      • Market Analysis
      • Leading Products and Competitors
    • Hepatitis Vaccine Market
      • Market Analysis
      • Leading Products and Competitors
    • Haemophilus Influenzae Type B Vaccine Market
      • Market Analysis
      • Leading Products and Competitors
    • Measles, Mumps and Rubella Vaccines
      • Market Analysis
    • Combination Vaccines Market
      • Market Analysis
      • Leading Products and Competitors
    • Pneumococcal Vaccine
      • Leading Products and Competitors
    • Poliovirus Vaccine
      • Market Analysis
      • Leading Products and Competitors
    • Varicella Vaccines
      • Market Analysis
      • Leading Products and Competitors
    • Other Vaccines Market
      • Market Analysis
      • Leading Products and Competitors

CHAPTER FOUR: ADULT PREVENTIVE VACCINES

  • Introduction
  • Adult Vaccine-Preventable Diseases: Facts and Figures
  • Global Virological Surveillance Program
  • Recommendations for Adult Immunizations
    • WHO International Health Regulations
  • Adult Vaccine Products
    • BCG Vaccines
    • Cervical Cancer Vaccines
    • Cholera Vaccines
    • Diphtheria-Tetanus Vaccines
    • Hepatitis Vaccines
      • Hepatitis A
      • Hepatitis B
    • Influenza Vaccines
    • Japanese Encephalitis Vaccines
    • Pneumococcal Disease Vaccines
    • Rabies Vaccines
    • Shingles Vaccine
    • Typhoid Vaccines
    • Yellow Fever Vaccines
  • Adult Vaccines in Development
  • Global Initiatives for Vaccine Research
    • Cancer
    • Cholera
    • HIV/AIDS
    • Helicobacter Pylori
    • Hepatitis
      • Hepatitis B
      • Hepatitis C
      • Hepatitis E
    • Herpesvirus
    • Influenza
    • Leishmaniasis
    • Malaria
    • Rabies
    • Tuberculosis
    • Typhoid Fever
    • West Nile Virus
  • The World Market for Adult Preventive Vaccines
    • Total Market Size and Forecast
    • Cervical Cancer Market
      • Market Analysis
      • Leading Products and Competitors
    • Hepatitis Market
      • Market Analysis
      • Leading Products and Competitors
    • Influenza Vaccine Market
      • Market Analysis
      • Leading Products and Competitors
      • Market Analysis
      • Leading Products and Competitors
    • Travel, DT, and Miscellaneous Vaccine Market
      • Market Analysis
      • Leading Products and Competitors

CHAPTER FIVE: VACCINES MARKET SUMMARY

  • Trends Driving the Vaccines Market
  • Market Size and Forecast
    • Vaccine Market Competitors
    • Pediatric Vaccines
      • Major Manufacturer' s Market Share
    • Adult Vaccines
      • Major Manufacturer' s Market Share

CHAPTER SIX: ISSUES AND TRENDS

  • Resistance to Immunization
  • Vaccine Safety
    • Vaccine Adverse Event Reporting System
    • The Vaccine Safety Datalink Project
    • The Vaccine Injury Compensation Program
  • Increased US Vaccine Availability
  • Vaccine Shortages
    • Preventing Shortages in the Developed Countries
  • A ' Gardasil Effect' in R&D?
  • Vaccines and Bioterrorism
    • Overview
    • Project Bioshield Act of 2004
    • National Bio and Agro-Defense Facility
    • Vaccine Treatment and Evaluation Units
    • Anthrax
    • Smallpox
    • Plague
    • Botulism
    • Tularemia
    • Viral Hemorrhagic Fevers
  • DNA Vaccination
  • Innovations in Vaccine Delivery Systems
    • Edible Vaccines
    • Mucosal Delivery
    • Intranasal Delivery
    • Oral Vaccines
    • Vaccine Patches

CHAPTER SEVEN: COMPANY PROFILES

  • Acambis plc
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • AlphaVax, Inc.
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
  • Avant Immunotherapeutics
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Bavarian Nordic A/S
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Baxter Healthcare
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Crucell
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Emergent biosolutions
    • History and Lines of Business
    • Strategic Acquisition and Alliance
    • Vaccine Products
    • Financial
  • GlaxoSmithKline
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Medimmune
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Merck & Co. Inc
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Nabi Biopharmaceuticals
    • History and Lines of Business
    • Strategic Alliance
    • Vaccine Products
    • Financial Information
  • Novartis
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
  • Pfizer
    • History and Lines of Business
    • Strategic alliances
    • Vaccine products
    • Financial Information
  • Pharmexa
    • History and Lines of Business
    • Strategic alliances
    • Vaccine Products
    • Financial Information
  • Sanofi Pasteur
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Wyeth
    • History and Lines of Business
    • Vaccine Products
    • Financial Information

APPENDIX: COMPANY DIRECTORY

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Figure 1-1: World Market for Pediatric Vaccines 2004-2013 Revenues
  • Figure 1-2: World Market for Adult Vaccines 2004-2013 Revenues

CHAPTER TWO: INTRODUCTION TO VACCINES

  • Table 2-1: Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2006
  • Table 2-2: Vaccine-Preventable Diseases, April 2008

CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES

  • Table 3-1: Global Immunization Rates by Vaccine Type 2006
  • Table 3-2: Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 2000-2006
  • Table 3-3: U.S. Recommended Childhood Immunization Schedule, 2008
  • Table 3-4: U.S. Recommended Adolescent Immunization Schedule, 2008
  • Table 3-5: Selected Pediatric Vaccines in Development, April 2008
  • Table 3-6: World Market for Pediatric Vaccines by Type (DTaP/DTP, Hep, HiB, MMR, Combos, Pneumococcal, Polio, Varicella, Others) 2004-2013
  • Figure 3-1: Market Share of Pediatric Vaccines by Type 2007
  • Figure 3-2: Market Share of Pediatric Vaccines, by Type 2013
  • Table 3-7: World DTP and DTaP Vaccine Market 2004-2013
  • Table 3-8: World Pediatric Hepatitis Vaccine Market 2004-2013
  • Table 3-9: World Hib Vaccine Market, 2004-2013
  • Table 3-10: World MMR Vaccines Market 2004-2013
  • Table 3-11: World Combination Vaccines Market 2004-2013
  • Table 3-12: World Pediatric Pneumococcal Vaccine Market 2004-2013
  • Table 3-13: World Poliovirus Vaccine Market 2004-2013
  • Table 3-14: World Varicella Vaccine Market 2004-2013
  • Table 3-15: Other Vaccines Market 2004-2013

CHAPTER FOUR: ADULT PREVENTIVE VACCINES

  • Table 4-1: Universal Adult Immunization Schedule 2008
  • Table 4-2: Adult Immunization Schedule for Populations with Special Medical Conditions, 2008
  • Table 4-3: Initiatives to Require HPV Vaccination by U.S. State, 2008
  • Table 4-4: Selected Adult Preventive Vaccines in Development, 2008
  • Table 4-5: World Market for Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/DT/Misc.), 2004-2013
  • Figure 4-1: Market Share of Adult Vaccines, by Type, 2007 (Cervical Cancer, Hepatitis, Influenza, Pneumococcal, Travel)
  • Figure 4-2: Market Share of Adult Vaccines, by Type, 2013
  • Table 4-6: World Cervical CancerVaccine Market 2004-2013
  • Table 4-7: World Hepatitis Vaccine Market 2004-2014
  • Table 4-8: World Influenza Vaccine Market 2004-2013
  • Table 4-9: CDC Goal to Double Flu Immunization by 2010 Group and Estimated Immunization Rate (2000 vs 2010)
  • Table 4-10: 2007 Estimated Population by Region and Selected Age Group
  • Table 4-11: World Pneumococcal Vaccine Market 2004-2013
  • Table 4-12: World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market 2004-2013

CHAPTER FIVE: VACCINES MARKET SUMMARY

  • Table 5-1: The World Vaccines Market by Vaccine Type 2004-2013
  • Figure 5-1: World Market for Vaccines by Type 2004-2013
  • Figure 5-2: World Market for Vaccines Share by Type, 2004, 2007 and 2013
  • Table 5-2: Major Manufacturers' Shares of the World Vaccine Market, 2007 154 Figure 5-3: 2007 World Vaccines Market Share, by Leading Competitors 155 Table 5-3: Major Manufacturer' s Shares of the World Pediatric Vaccine Market 2007
  • Figure 5-5: Market Share of Pediatric Vaccines Market, 2007 157 Table 5-4: Major Manufacturer' s Shares of the World Adult Vaccine Market 2007
  • Figure 5-6: Market Share of Adult Vaccines Market 2007

CHAPTER SIX: ISSUES AND TRENDS

  • Table 6-1: Selected Companies/Laboratories Developing Biodefense Vaccines
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.